Virtual Library

Start Your Search

  • WCLC 2016

    17th World Conference on Lung Cancer

    Access to all presentations that occur during the 17th World Conference on Lung Cancer in Vienna, Austria

    Presentation Date(s):  
    • Dec 4 - 7, 2016
    • Total Presentations: 2466

    To review abstracts of the presentations below, narrow down your search by using the Filter options below, and then select the session listing of your choice. Click the "+" for a presentation to expand & view the corresponding Abstract details.

    Presentations will be available 24 hours after their live presentation time

Filter Results:

Show Only Available Presentations

  • +

    SC10 - Squamous Cell NSCLC

    • Type: Science Session
    • Track: Advanced NSCLC
    • Presentations: 5
    • Moderators:D.R. Gandara
    • Coordinates: 12/05/2016, 16:00 - 17:30, Strauss 3
  • +

    P3.02b - Poster Session with Presenters Present

    • Type: Poster Presenters Present
    • Track: Advanced NSCLC
    • Presentations: 126
    • Coordinates: 12/07/2016, 14:30 - 15:45, Hall B (Poster Area)
    • +

      P3.02b-007 - Differential Efficacy of Gefitinib in Exon 19 or Exon 21 Mutated Adenocarcinoma Lung

      14:30 - 14:30  |  Author(s): A. Goel

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P3.02b-055 - Impact of Pemetrexed Chemotherapy in Exon 19 or Exon 21 Mutated NSCLC

      14:30 - 14:30  |  Author(s): V.T. Talreja

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P3.02b-058 - Second-Line Therapy in EGFR Activating Mutation Positive Advanced NSCLC: Analysis from a Randomized Phase III First-Line Trial

      14:30 - 14:30  |  Author(s): A. Ramaswamy

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P3.02b-065 - Third Line Therapy in EGFR Positive Advanced Non-Small Cell Lung Cancer

      14:30 - 14:30  |  Author(s): N. Pande

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P3.02b-090 - Pemetrexed versus Gefitinib in EGFR Mutation Positive Lung Cancer: Results of a Phase 3 Study from India

      14:30 - 14:30  |  Author(s): K. Prabhash

      • Abstract

      Loading...

    • +

      P3.02b-094 - Rebiopsy Post Progression in EGFR Mutated Lung Cancer

      14:30 - 14:30  |  Author(s): A. Chandrasekharan

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.